Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement.

Abstract:

:This study sought to identify the effect of drug reimbursability--a decision made in France by the National Authority for Health--on physicians' prescribing practices for a diet drug such as rimonabant, approved for obese or overweight patients with type-2 diabetes. A cross-sectional survey of French general practitioners (GPs) presented a case-vignette about a patient for whom this drug is indicated in two alternative versions, differing only in its reimbursability, to two separate randomized subsamples of GPs in early 2007, before any decision was made about reimbursement. The results indicate that (i) more than 20% of GPs in private practice would be willing to prescribe a non-reimbursed diet drug for patients with obesity complicated by type 2 diabetes; (ii) the number of GPs willing to prescribe it would increase by 47.6% if the drug were reimbursed, and (iii) such a drug would be adopted at a higher rate by GPs who have regular contacts with pharmaceutical sales representatives. In France, unlike most other countries, drug reimbursement status is a signal of quality. However, our results suggest that a significant proportion of GPs would spontaneously adopt anti-obesity drugs even if they were not reimbursed. Decisions about reimbursement of pharmaceutical products should be made taking into account that reimbursement is likely to intensify prescription.

journal_name

Fundam Clin Pharmacol

authors

Verger P,Rolland S,Paraponaris A,Bouvenot J,Ventelou B

doi

10.1111/j.1472-8206.2009.00779.x

subject

Has Abstract

pub_date

2010-08-01 00:00:00

pages

509-16

issue

4

eissn

0767-3981

issn

1472-8206

pii

FCP779

journal_volume

24

pub_type

杂志文章,随机对照试验
  • Interaction of chelerythrine with inositol phosphate metabolism.

    abstract::Chelerythrine, a potent inhibitor of protein kinase C (PKC), was evaluated for its effect on inositol phosphate (IP) metabolism in newborn rat cardiomyocytes in culture. In a first step, we evaluated the effect of chelerythrine on IP accumulation in basal conditions. For a 10(-4) M dose, 5-phosphatase activity (which ...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1472-8206.2002.00069.x

    authors: Le Corvoisier P,Lacotte J,Laplace M,Crozatier B

    更新日期:2002-02-01 00:00:00

  • The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.

    abstract::Research in the last two decades has unveiled an important role for neuroinflammation in the degeneration of the nigrostriatal dopaminergic (DA) pathway that constitutes the pathological basis of the prevailing movement disorder, Parkinson's disease (PD). Neuroinflammation is characterized by the activation of brain g...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.2008.00616.x

    authors: Dutta G,Zhang P,Liu B

    更新日期:2008-10-01 00:00:00

  • Pharmacokinetics of dextromoramide in surgical patients.

    abstract::The pharmacokinetics of the narcotic analgesic dextromoramide was investigated by means of a specific GC-MS method in 9 patients who were given a single oral dose of the drug (7.5 mg) together with an anticholinergic before undergoing minor orthopedic surgery. Dextromoramide was rapidly absorbed from the gastrointesti...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1989.tb00027.x

    authors: Pagani I,Barzaghi N,Crema F,Perucca E,Ego D,Rovei V

    更新日期:1989-01-01 00:00:00

  • Short- and long-term effects of treatment of chronic hepatitis B and delta virus by IFN.

    abstract::Chronic hepatitis B virus (HBV) infection is a common infectious disease in the world. Two percent of the patients with chronic HBV infection will develop cirrhosis each year, and will die prematurely from cirrhosis or hepatocellular carcinoma. So far interferon alfa and lamivudine are the only effective drugs. Interf...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1046/j.1472-8206.2003.00194.x

    authors: Ormeci N

    更新日期:2003-12-01 00:00:00

  • Controlled ingestion of kaolinite (5%) modulates enteric nitrergic innervation in rats.

    abstract::We have previously shown that kaolinite slowed down gastric emptying and intestinal transit and induced changes in enteric mechanical activities. As gastric emptying and intestinal transit have been shown to be regulated by nitric oxide (NO), the effect of an imposed ingestion of kaolinite on enteric nitrergic innerva...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/fcp.12040

    authors: Voinot F,Fischer C,Schmidt C,Ehret-Sabatier L,Angel F

    更新日期:2014-08-01 00:00:00

  • Surrogate endpoints in randomized cardiovascular clinical trials.

    abstract::Surrogate endpoints predict the occurrence and timing of a clinical endpoint of interest (CEI). Substitution of a surrogate endpoint for a CEI can dramatically reduce the time and cost necessary to complete a Phase III clinical trial. However, assurance that use of a surrogate endpoint will result in a correct conclus...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.2010.00865.x

    authors: Domanski M,Pocock S,Bernaud C,Borer J,Geller N,Revkin J,Zannad F

    更新日期:2011-08-01 00:00:00

  • Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase.

    abstract::To date, no reports of hypersensitivity reactions (HSRs) among nonsteroidal anti-inflammatory drugs (NSAIDs) according to cyclo-oxygenase (COX) selectivity and chemical groups have been published in a single study. The present study assessed the reporting frequency of HSRs for NSAIDs based on their relative inhibitory...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/fcp.12463

    authors: Bakhriansyah M,Meyboom RHB,Souverein PC,de Boer A,Klungel OH

    更新日期:2019-10-01 00:00:00

  • NG-nitro-L-arginine methyl-ester: a muscarinic receptor antagonist?

    abstract::The effect of the nitric oxide synthase inhibitor NG-Nitro-L-arginine methyl ester (L-NAME) towards muscarinic receptors was studied in vitro and in vivo. L-NAME displaced the antimuscarinic ligand [3H]quinuclidinyl benzilate ([3H]QNB) from its specific binding sites in rat cerebral cortex and cerebellum homogenates w...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1997.tb00843.x

    authors: Hellmich B,Gyermek L

    更新日期:1997-01-01 00:00:00

  • A GppNHp-insensitivity factor modulates the activation of beta-adrenoceptor-coupled Gs protein in rat cortex and cerebellum.

    abstract::The effect known as the GTP-shift refers to the complete conversion of receptors from the high- to the low agonist-affinity state in the presence of an excess of GTP or one of its analogs. 5'-Guanylylimidodiphosphate (GppNHp) was able to fully suppress the high (-)-isoproterenol-affinity of beta-adrenoceptors (beta AR...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1999.tb00335.x

    authors: Garnier V,Zini R,Tillement JP

    更新日期:1999-01-01 00:00:00

  • Quality of life assessment in therapeutic trials: rationale for and presentation of a more appropriate instrument.

    abstract::In therapeutic trials, quality of life studies are usually based on a health model which results in a restrictive view. Therefore, it is important to clearly define the concept of the quality of life, since ambiguous concepts can alter the results. The key to this problem is the clear distinction between the two compo...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.1992.tb00120.x

    authors: Gerin P,Dazord A,Boissel J,Chifflet R

    更新日期:1992-01-01 00:00:00

  • Choice of designs and doses for early phase trials.

    abstract::This paper reviews state-of-art statistical designs for dose-escalation procedures in first-into-man studies. The main focus will be on studies in oncology, as most statistical procedures for phase I trials have been proposed in this context. Extensions to situations such as the observation of bivariate outcomes and h...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.2004.00226.x

    authors: Zhou Y

    更新日期:2004-06-01 00:00:00

  • Prevention of restenosis after coronary angioplasty: towards a molecular approach?

    abstract::Restenosis after coronary angioplasty, the main limitation of interventional cardiology, remains an unsolved issue. The failure to-date of all pharmacological attempts at prevention has prompted the development of alternative strategies. A mechanistic approach to the problem of restenosis is based on the assumption th...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.1995.tb00259.x

    authors: Feldman LJ,Riessen R,Steg PG

    更新日期:1995-01-01 00:00:00

  • Dopamine formation, from its immediate precursor 3,4-dihydroxyphenylalanine, along the rat digestive tract.

    abstract::The formation of dopamine, from L-3,4-dihydroxyphenylalanine (L-dopa), in fragments of non-glandular and glandular stomach, duodenum, jejunum, ileum and proximal and distal colon of the rat was examined. The deamination of newly-formed dopamine into 3,4-dihydroxyphenylacetic acid (dopac) was also studied. The synthesi...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1993.tb00237.x

    authors: Vieira-Coelho MA,Soares-da-Silva P

    更新日期:1993-01-01 00:00:00

  • Prostaglandin E synthase in the pathophysiology of arthritis.

    abstract::Prostaglandin E synthase (PGES) is a recently identified terminal enzyme that acts downstream of cyclooxygenase and catalyzes the conversion of prostaglandin (PG) H2 to PGE2. At least three isozymes have been cloned so far, which are called membrane-associated PGES (mPGES)-1, mPGES-2, and cytosolic PGES. Among them, m...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.2005.00316.x

    authors: Kojima F,Kato S,Kawai S

    更新日期:2005-06-01 00:00:00

  • Effect of apomorphine on adrenal medullary catecholamine levels.

    abstract::The effects of the dopamine receptor agonist, apomorphine, on the total catecholamine content of the adrenal medulla were studied in normotensive rats. Apomorphine (3, 15, 30 mg/kg SC) induced a dose-dependent decrease in catecholamine content of the adrenal gland. The action of apomorphine was suppressed by previous ...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1989.tb00467.x

    authors: Montastruc JL,Gaillard G,Rascol O,Tran MA,Montastruc P

    更新日期:1989-01-01 00:00:00

  • Metformin potentiates the chemotherapeutic effects of doxorubicin on 2-amino-1-methyl-6-phenylimidazo[4,5b] pyridine-induced Mammary Carcinoma in rats.

    abstract::This study was carried out to evaluate the antitumor activity of Metformin (Met) and its impending utility to potentiate the chemotherapeutic action of doxorubicin on 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP)-induced rat mammary carcinogenesis. Female Sprague -Dawley (SD) rats were divided into seven group...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/fcp.12604

    authors: Salim E,El-Sisi AE,Sokar S,El-Sayad M,Moussa E

    更新日期:2020-09-09 00:00:00

  • A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.

    abstract::A meta-analysis was performed on the results of clinical trials of buflomedil in intermittent claudication. The analysis used results from 744 patients enrolled in ten studies, conducted at 42 centers in seven countries. All studies were randomized, double-blind, placebo-controlled trials which measured improvement in...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 临床试验,杂志文章,meta分析

    doi:10.1111/j.1472-8206.1995.tb00515.x

    authors: Walker GA,Mac Hannaford JC

    更新日期:1995-01-01 00:00:00

  • Thrombin-stimulated proliferation is mediated by endothelin-1 in cultured rat gingival fibroblasts.

    abstract::Abstract Endothelin-1 (ET-1) appears to be involved in drug-induced proliferation of gingival fibroblasts. Thrombin induces proliferation of human gingival fibroblasts via protease-activated receptor 1 (PAR1). In this study, using cultured rat gingival fibroblasts, we investigated whether thrombin-induced proliferatio...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.2009.00786.x

    authors: Ohuchi N,Hayashi K,Iwamoto K,Koike K,Kizawa Y,Nukaga M,Kakegawa T,Murakami H

    更新日期:2010-08-01 00:00:00

  • Restoration of brain protein synthesis in mature and aged rats by a DA agonist, piribedil.

    abstract::Brain ageing affects numerous cerebral metabolic pathways such as cerebral glucose consumption or protein synthesis rate. The pharmacological effect of a mixed D1-D2 dopaminergic agonist, piribedil, on this last metabolism is reported. Cerebral Protein Synthesis Rate (CPSR) was measured by the [35S]L-methionine autora...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1995.tb00521.x

    authors: Bustany P,Trenque T,Crambes O,Moulin M

    更新日期:1995-01-01 00:00:00

  • Preclinical assessment of a new transdermal delivery system for clonidine (M-5041T).

    abstract::The effects of a new transdermal delivery system for clonidine (M-5041T) on hypotensive effect, urine volume, plasma renin activity (PRA) and antidiuretic hormone (ADH) in spontaneously hypertensive rats (SHRs) were compared to the effects of the continuous infusion of clonidine. Both M-5041T (1.5 and 4.5 mg/kg) and t...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1996.tb00149.x

    authors: Naruse T,Ishida T,Ishii R,Tagawa T

    更新日期:1996-01-01 00:00:00

  • Cardioprotection of cariporide evaluated by plasma myoglobin and troponin I in myocardial infarction in pigs.

    abstract::The cardioprotective effects of cariporide were investigated against myoglobin and troponin I elevation in a model of myocardial infarction in pig, and the possible relationship between these markers and myocardial infarct size. The left circumflex coronary artery was ligated for 60-min and then reperfused for 48-h. P...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.2006.00394.x

    authors: Létienne R,Bel L,Bessac AM,Denais D,Degryse AD,John GW,Le Grand B

    更新日期:2006-04-01 00:00:00

  • Can positron emission tomography facilitate paediatric drug development?

    abstract::Advances in paediatric clinical pharmacology are interdependent with a better understanding of the influence of growth on drug disposition and action. In this field, there is an increasing need for non-invasive drug monitoring approaches. This paper aims to discuss the role of positron emission tomography in such prac...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1472-8206.2008.00650.x

    authors: Zimmer L

    更新日期:2008-12-01 00:00:00

  • C.B-17 SCID mice develop epicardial calcinosis with unaltered cardiac function.

    abstract::Inbred mouse strains are the most widely used mammalian model organism in biomedical research owing to ease of genetic manipulation and short lifespan; however, each inbred strain possesses a unique repertoire of deleterious homozygous alleles that can make a specific strain more susceptible to a particular disease. I...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/fcp.12398

    authors: Raghunathan S,Reynolds CL,Schwartz RJ,Stewart MD,McConnell BK

    更新日期:2019-02-01 00:00:00

  • Similia similibus obscurantur: the pharmacological clinical activity bias I. A prototype model to correct a disease-drug interaction leading to misestimations of drug-attributable side effects.

    abstract::Drugs have side effects that manifest as signs or symptoms which are sometimes undistinguishable from signs or symptoms of active disease. The conventional approximation of the rate of side effects of drugs is by subtracting the rate of signs and symptoms in the placebo group from that in the drug group. This measures...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1995.tb00537.x

    authors: Bernheim JL,Vrana I

    更新日期:1995-01-01 00:00:00

  • Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.

    abstract::Corticotropin-releasing factor (CRF) is a hypothalamic 41-amino acid peptide which stimulates corticotropin (ACTH) release from the anterior pituitary and is also involved in the body response to stress. CRF1 receptors represent a potential target for novel antidepressant/anxiolytic drugs. The aim of the present study...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1999.tb00007.x

    authors: Schoeffter P,Feuerbach D,Bobirnac I,Gazi L,Longato R

    更新日期:1999-01-01 00:00:00

  • Ivermectin and filariasis.

    abstract::Ivermectin, a parasiticide that long ago proved its worth in veterinary medicine, became one of the most effective tools for control programs against human filarial diseases in the 1980s. It is provided at no cost, is effective against microfilariae (blocking their transmission) and can be administered annually as a s...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1046/j.1472-8206.2003.00170.x

    authors: Richard-Lenoble D,Chandenier J,Gaxotte P

    更新日期:2003-04-01 00:00:00

  • Effect of lipopolysaccharide treatment on neurogenic contraction and noradrenaline release in rat arteries.

    abstract::In the present study, contractile responses and [3H]-noradrenaline overflow evoked by electrical field stimulation were assessed, respectively, in the small mesenteric artery and in tail artery removed from rats pre-treated with either saline or lipopolysaccharide (LPS). In small mesenteric arteries, LPS treatment did...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.2000.tb00445.x

    authors: Ohlmann P,Martínez MC,Bucher B,Andriantsitohaina R,Muller B,Schneider F,Stoclet JC

    更新日期:2000-11-01 00:00:00

  • Clinical pharmacology of single- and multiple-ascending doses of ACT-178882, a new direct renin inhibitor, and its pharmacokinetic interaction with food and midazolam.

    abstract::This study investigated the tolerability, safety, pharmacokinetics, and pharmacodynamics of ACT-178882, a new direct renin inhibitor, as well as its interaction with food and midazolam. Healthy male subjects received either single (10-1000 mg) or multiple doses (30-600 mg) administered once daily for 14 days of ACT-17...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1472-8206.2012.01060.x

    authors: Dingemanse J,Nicolas L,Binkert C

    更新日期:2013-12-01 00:00:00

  • Rabbit articular chondrocytes: an in vitro model for studying the effect of sodium aurothiopropanol sulfonate on proliferation kinetics, type II collagen phenotype and mitochondrial activity.

    abstract::Despite the benefits of chrysotherapy the responsible mechanism of action of gold compounds remains unclear. At a concentration of 5 x 10(-4) M, sodium aurothiopropanol sulfonate (SAS) modified the in vitro proliferation kinetics of articular chondrocytes by reducing growth, viability and plating efficiency. Flow cyto...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.1988.tb00621.x

    authors: Ronot X,Hainque B,Christen MO,Froger B,Hartmann DJ,Adolphe M,Lechat P

    更新日期:1988-01-01 00:00:00

  • Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additional effect of dexamethasone.

    abstract::The effects of hydrocortisone, triamcinolone, prednisolone and dexamethasone have been investigated in vitro using mitochondria isolated from rat brain. Respiratory control ratio (RCR), oxygen consumption, ATP synthesis, enzymatic activities of involved complexes and superoxide anion generation have been measured to a...

    journal_title:Fundamental & clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1472-8206.2000.tb00432.x

    authors: Morin C,Zini R,Simon N,Charbonnier P,Tillement JP,Le Louet H

    更新日期:2000-09-01 00:00:00